Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 29;75(1):75.
doi: 10.1186/s43044-023-00401-1.

Effect of body mass index on N-terminal pro-brain natriuretic peptide values in patients with heart failure

Tuan Ha Manh  1 , Duong Do Anh  2 , Tung Le Viet  3   4
Affiliations

Effect of body mass index on N-terminal pro-brain natriuretic peptide values in patients with heart failure

Tuan Ha Manh et al. Egypt Heart J. .

Abstract

Background: N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a biomarker used for the diagnosis of heart failure. There is a relationship between NT-proBNP levels and body mass index (BMI). The study aimed to explore the impact of BMI on NT-proBNP concentrations and to examine whether other factors independent of or combined with BMI affect NT-proBNP values in patients with heart failure.

Results: A total of 293 participants were recruited. The mean age was 68.9 ± 13.2 years, males accounted for 46.4% of the total cohort, the mean BMI was 23.1 ± 4.0 kg/m2, and the median NT-proBNP level was 3776 (1672-8806) pg/ml. There was an inverse relationship between BMI and log NT-proBNP (r = - 0.29; p < 0.001, Spearman correlation). Each standard deviation increase in BMI (4 kg/m2) was associated with a 7% decrease in NT-proBNP values in the total cohort. The independent inverse determinants of NT-proBNP other than BMI were male gender and eGFR, while the variables directly correlated to NT-proBNP were LVEF ≤ 40% and NYHA class III-IV heart failure.

Conclusions: There is an inverse association between BMI and NT-proBNP levels. However, the correlation is weak, and there are other variables that have a significant impact on the NT-proBNP values as well. The NT-proBNP levels are still valuable in the diagnosis of heart failure regardless of BMI status.

Keywords: Body mass index (BMI); Heart failure; N-terminal pro-B-type natriuretic peptide (NT-proBNP); Obesity.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Box plots show median NT-proBNP values in lean, overweight, and obese heart failure patients
Fig. 2
Fig. 2
Correlation between log NT-proBNP values with body mass index (BMI)
Fig. 3
Fig. 3
Correlation between log NT-proBNP values with body mass index (BMI) in male
See this image and copyright information in PMC

References

    1. Singh S, Pandey A, Neeland IJ. Diagnostic and prognostic considerations for use of natriuretic peptides in obese patients with heart failure. Prog Cardiovasc Dis. 2020;63(5):649–655. doi: 10.1016/j.pcad.2020.09.006. - DOI - PMC - PubMed
    1. Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol. 2007;50(25):2357–2368. doi: 10.1016/j.jacc.2007.09.021. - DOI - PubMed
    1. Heil B, Tang WH. Biomarkers: their potential in the diagnosis and treatment of heart failure. Cleve Clin J Med. 2015;82(12 Suppl 2):S28–35. doi: 10.3949/ccjm.82.s2.05. - DOI - PubMed
    1. Palazzuoli A, Gallotta M, Quatrini I, Nuti R. Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure. Vasc Health Risk Manag. 2010;6:411–418. doi: 10.2147/VHRM.S5789. - DOI - PMC - PubMed
    1. Madamanchi C, Alhosaini H, Sumida A, Runge MS. Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure. Int J Cardiol. 2014;176(3):611–617. doi: 10.1016/j.ijcard.2014.08.007. - DOI - PMC - PubMed

LinkOut - more resources